During the past decade, Szpital Specjalistyczny im. J. Dietla conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Szpital Specjalistyczny im. J. Dietla" #1 sponsor was "Bayer" with 2 trials, followed by "Hoffmann-La Roche" with 1 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Mabion SA" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "Szpital Specjalistyczny im. J. Dietla" are "Heart Failure" (2 trials), "Rheumatoid Arthritis" (2 trials), "Systemic Lupus Erythematosus" (2 trials), "AOSD" (1 trials) and "Giant Cell Arteritis" (1 trials). Many other conditions were trialed in "Szpital Specjalistyczny im. J. Dietla" in a lesser frequency.

Most popular intervention types in "Szpital Specjalistyczny im. J. Dietla" are "Drug" (8 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Neladenoson bialanate (BAY1067197)" (2 trials), "Cenerimod 0.5 mg" (1 trials), "Cenerimod 1 mg" (1 trials) and "Cenerimod 2 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Szpital Specjalistyczny im. J. Dietla" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Szpital Specjalistyczny im. J. Dietla". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Szpital Specjalistyczny im. J. Dietla, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Szpital Specjalistyczny im. J. Dietla, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Szpital Specjalistyczny im. J. Dietla has several departments that took part in Clinical trials: "Szpital Specjalistyczny im Jozefa Dietla; Centrum Reumatologii, Immunologii i Rehabilitacji, I Oddzi" - 2 trials, "Szpital Specjalistyczny im. J. Dietla w Krakowie, Oddzial Kardiologii" - 2 trials